Systemic exposure to tobramycin after local antibiotic treatment with calcium sulphate as carrier material

Archives of Orthopaedic and Trauma Surgery

Volumn 131, Issue 5, 2011, Pages 657-662

  Wahl, Peter ^a   Livio, Françoise ^b   Jacobi, Matthias ^a   Gautier, Emanuel ^a   Buclin, Thierry ^b  

^a Hopital Cantonal de Fribourg   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Calcium sulphate; Local antibiotherapy; Pharmacokinetics; Tobramycin

Indexed keywords

CALCIUM SULFATE; OSTEOSET T; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EXPOSURE; DRUG HALF LIFE; DRUG RELEASE; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BONE DISEASES, INFECTIOUS; CALCIUM SULFATE; FEMALE; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; SOFT TISSUE INFECTIONS; TOBRAMYCIN;

EID: 79955943209     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-010-1192-2     Document Type: Article

References (37)

1. Buchholz HW, Engelbrecht H (1970) Depot effects of various antibiotics mixed with Palacos resins. Chirurg 41(11):511-515
2. Blaha JD, Calhoun JH, Nelson CL, Henry SL, Seligsnon D et al (1993) Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop Relat Res 295:8-12 (Pubitemid 23299624)
3. Henry SL, Galloway KP (1995) Local antibacterial therapy for the management of orthopaedic infections: pharmacokinetic considerations. Clin Pharmacokinet 29(1):36-45
4. Kanellakopoulou K, Giamarellos-Bourboulis EJ (2000) Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59(6):1223-1232 (Pubitemid 30410141)
5. Gitelis S, Brebach GT (2002) The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg 10(1):53-60 (Pubitemid 35332424)
6. Van Raaij TM, Visser LE, Vulto AG, Verhaar JAN (2002) Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty. J Arthroplasty 17(2):948-950
7. Springer BD, Lee GC, Osmon D, Haidukewych GJ, Hanssen AD, Jacofsky DJ (2004) Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res 427:47-51
8. Anagnostakos K, Wilmes P, Schmitt E, Kelm J (2009) Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop 80(2):193-197
9. McKee MD, Wild LM, Schemitsch EH, Waddell JP (2002) The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: Early results of a prospective trial. J Orthop Trauma 16(9):622-627 (Pubitemid 35214851)
10. Rauschmann MA, Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L et al (2005) Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26:2677-2684 (Pubitemid 39600720)
11. Downes S, Brown AE, Murkherjee S (1985) The clearance of gentamicin from antibiotic-loaded bone cement. Int Orthop 9:205-207 (Pubitemid 16196482)
12. Walenkamp GHIM, Vree TB, Van Rens TJG (1986) Gentamicin-PMMA beads: pharmacokinetic and nephrotoxicological study. Clin Orthop Relat Res 205:171-183 (Pubitemid 16011268)
13. Dreesmann H (1892) Über Knochenplombierung. Beitr Klin Chir 9:804-810
14. Peltier LF (1959) The use of plaster of Paris to fill large defects in bone: a preliminary report. Am J Surg 97:311-315
15. Kelly CM, Ross MW, Gitelis S, Hartjen C, Watson JT, Kim PT (2001) The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop Relat Res 382:42-50 (Pubitemid 32047428)
16. Petruskevicius J, Nielsen S, Kaalund S, Knudsen PR, Overgaard S (2002) No effet of Osteoset®, a bone graft substitute, on bone healing in humans. A prospective randomized double-blind study. Acta Orthop Scand 73(5):575-578
17. Bibbo C, Patel DV (2006) The effect of demineralised bone matrix-calcium sulphate with vancomycin in calcaneal fracture healing and infection rates: a prospective study. Foot Ankle Int 27(7):487-493
18. Chang W, Colangeli M, Colangeli S, Di Bella C, Gozzi E, Donati D (2007) Adult osteomyelitis: debridement versus debridement plus Osteoset T® pellets. Acta Orthop Belg 73:238-244
19. Helgeson MD, Potter BK, Tucker CJ, Frisch HM, Shawen SB (2009) Antibiotic-impregnated calcium sulfate use in combat-related open fractures. Orthopedics 32:323-327
20. Krause FG, de Vries G, Meakin C, Kalla TP, Younger AS (2009) Outcome of transmetatarsal amputations in diabetics using antibiotic beads. Foot Ankle Int 30(6):486-493
21. Nelson CL, McLaren SG, Skinner RA, Smeltzer MS, Thomas JR, Olsen KM (2002) The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulphate tobramycin pellets. J Orthop Res 20:643-647 (Pubitemid 34822981)
22. Turner TM, Urban RM, Hall DJ, Chye PC, Segreti J, Gitelis S (2005) Local and systemic levels of tobramycin delivered from calcium sulphate bone graft substitute pellets. Clin Orthop Relat Res 437:97-104 (Pubitemid 41099073)
23. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
24. Livio F, Wahl P, Csajka C, Gautier E, Buclin T Systemic exposure in orthopaedic patients treated with tobramycin-laden bone graft substitute. Br J Clin Pharmacol (submitted)
25. Dahlgren JG, Anderson ET, Hewitt WL (1975) Gentamicin blood levels: a guide to nephrotoxicity. J Antimicrob Chemother 8(1):58-62
26. McCormack JP, Jewesson PJ (1992) A critical reevaluation of the "therapeutic range" of aminoglycosides. Clin Infect Dis 14:320-339
27. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH (1997) Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 39:677-686
28. Moerike K, Schwab M, Klotz U (1997) Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations. Drugs Aging 10(4):259-277
29. Turnidge J (2003) Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin N Am 17:503-528
30. Triggs E, Charles B (1999) Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly. Clin Pharmacokinet 37(4):331-341 (Pubitemid 29515697)
31. Burton ME, Shaw LM, Schentag JJ, Evans WE (2006) Aminoglycosides. In: Troy D, Hauber M, Remsberg C (eds) Applied pharmacokinetics and pharmacodynamics - principles of therapeutic drug monitoring, 4th edn. Williams and Wilkins, Philadelphia, pp 285-327
32. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE (1995) Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 9(5):401-406
33. Sterling GJ, Crawford S, Potter JH, Koerbin D, Crawford R (2003) The pharmacokinetics of simplex-tobramycin bone cement. J Bone Joint Surg Br 85:646-649 (Pubitemid 36927025)
34. Swieringa AJ, Tulp NJA (2005) Toxic serum gentamicin levels after the use of gentamicin-loaded sponges in infected total hip arthroplasty. Acta Orthop 76(1):75-77
35. Levey AS, Posch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461-7034
36. Giannelli SV, Patel KV, Windham BG, Pizzarelli F, Ferrucci L, Guralnik JM (2007) Magnitude of under ascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc 55(6):816-823 (Pubitemid 47011053)
37. Hahn T, Yao S, Dunford LM, Thomas J, Lohr J et al (2009) A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogenic BMT. Biol Blood Marrow Transplant 15:574-579